Infections, antibiotics more common in type 2 diabetesJuly 16, 2016DiabetesEndocrinologyInfectious Diseases
Newer insulin glargine formula curbs nocturnal hypoglycemiaJuly 13, 2016DiabetesEndocrinologyNephrology
FDA panel narrowly endorses empagliflozin’s cardiovascular mortality benefitJune 29, 2016CardiologyDiabetesEndocrinology
Artificial pancreas can improve inpatient glycemic control in type 2 diabetesJune 21, 2016DiabetesEndocrinology
VIDEO: Telehealth program cuts cost, hospitalizations for chronic patientsMay 20, 2016DiabetesHealth PolicyPulmonologyCardiologyEndocrinology
FDA alert: Canagliflozin use may be associated with toe, foot amputationsMay 18, 2016DiabetesEndocrinology
No rise in serious HF seen in patients taking saxagliptin or sitagliptinApril 25, 2016DiabetesCardiologyEndocrinology
FDA adds safety warnings to certain type 2 diabetes medicationsApril 5, 2016DiabetesCardiologyEndocrinologyNephrology
VIDEO: New ACC consensus guidance addresses nonstatin therapiesApril 3, 2016DiabetesCardiologyEndocrinology
